NMS · Medical - Devices
CVRX (CVRX) Stock
$3.04
+2.70%
NMS: CVRX
Healthcare
Valuation
Financials & Margins
Ownership
Insiders Held9.55%
Institutions Held63.58%
Institutions Float Held70.29%
About CVRX
CVRX is led by CEO Kevin Hykes, employs 206 people, headquartered in US, publicly traded since 2021.
CVRX stock trades at $3.04 with a market capitalization of $80.67M. The stock is valued at a price-to-earnings (P/E) ratio of -2.98, price-to-book of 4.13, price-to-sales of 2.85. Over the past 52 weeks the stock has ranged between $2.71 and $11.30, and currently trades 73.1% below its 52-week high.
On profitability, CVRX generates a return on equity (ROE) of -135.90%, return on capital employed of -127.50%, an operating margin of -89.47%, a net profit margin of -89.15%.